GlassScriptPhysician profile
Aletha Brackett
NPI 1255079901
$6,209.58
in general payments reported to CMS, 2019-2025
21 companies · $2,295 in 2025
The $2,295 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $796 · 2023: $2,350 · 2024: $769 · 2025: $2,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,975 · Travel and Lodging: $1,385 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,974.82 |
| Travel and Lodging | $1,384.92 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,373.12 | 2023-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Saluda Medical Americas, INC. | $1,871.31 | 2023-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $748.19 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $272.04 | 2022-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $212.65 | 2023-2024 | Xtampza, Belbuca |
| Mml US, INC. | $197.83 | 2023-2025 | Reactiv8 |
| Si-Bone, INC. | $129.76 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $105.33 | 2022-2024 | Ztlido |
| Spinal Simplicity, LLC | $69.40 | 2022-2025 | Ha Minuteman G3-R |
| Ani Pharmaceuticals, INC. | $29.70 | 2024 | Purified Cortrophin Gel |
| Nalu Medical, INC. | $25.13 | 2024 | Nalu Neurostimulation System |
| Alpha Orthopedic Systems | $21.86 | 2022 | |
| Almatica Pharma LLC | $19.76 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.01 | 2024 | |
| Merck Sharp & Dohme LLC | $18.49 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $17.49 | 2023 | Horizant |
| Valinor Pharma, LLC | $16.73 | 2025 | Movantik |
| Abbvie INC. | $16.57 | 2025 | |
| Nevro Corp. | $16.24 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.66 | 2023 | Quviviq |
| Pacira Pharmaceuticals Incorporated | $13.31 | 2023 | Zilretta, Exparel, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aletha Brackett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.